Mishra, P., Bhurani, D., Khan, M. A., & Nidhi. (2025). Deranged cytokine levels are linked to cancer-related cognitive impairment in lymphoma patients receiving R-CHOP chemotherapy. Leukemia & Lymphoma, 66(3), 516. https://doi.org/10.1080/10428194.2024.2424373
Chicago Style (17th ed.) CitationMishra, Pinki, Dinesh Bhurani, Mohd Ashif Khan, and Nidhi. "Deranged Cytokine Levels Are Linked to Cancer-related Cognitive Impairment in Lymphoma Patients Receiving R-CHOP Chemotherapy." Leukemia & Lymphoma 66, no. 3 (2025): 516. https://doi.org/10.1080/10428194.2024.2424373.
MLA (9th ed.) CitationMishra, Pinki, et al. "Deranged Cytokine Levels Are Linked to Cancer-related Cognitive Impairment in Lymphoma Patients Receiving R-CHOP Chemotherapy." Leukemia & Lymphoma, vol. 66, no. 3, 2025, p. 516, https://doi.org/10.1080/10428194.2024.2424373.